Medical University of Vienna

Vienna, Austria

40 recruiting

Showing 120 of 119 trials

Recruiting

Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

Liver CirrhosisLiver TransplantationAcute Liver Failure+1 more
University Medical Center Groningen10,000 enrolled2 locationsNCT07585890
Recruiting
Phase 3

Vorasidenib Maintenance for IDH Mutant Astrocytoma

IDH-mutant Grade 2 or 3 Astrocytoma
European Organisation for Research and Treatment of Cancer - EORTC468 enrolled33 locationsNCT06809322
Recruiting

The DefiPace Study

Post-operative Atrial Fibrillation (POAF)
Institut für Pharmakologie und Präventive Medizin450 enrolled10 locationsNCT04804748
Recruiting
Phase 2

Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

Advanced Breast CancerHormone Receptor-Positive Breast CarcinomaAdvanced Breast Carcinoma
MedSIR200 enrolled79 locationsNCT06486883
Recruiting
Phase 3

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age related macular degeneration (AMD)Geographic Atrophy (GA)
Regeneron Pharmaceuticals975 enrolled218 locationsNCT06541704
Recruiting
Not Applicable

Education & Care in RARE: Efficacy of Targeted Psychoeducational Intervention Among Pediatric Rare Disease Patients

Rare DisordersOrphan DiseasesPediatric Diseases+1 more
Medical University of Vienna100 enrolled7 locationsNCT06729554
Recruiting

Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants

Lung InjuryUltrasonographyElectric Impedance+2 more
Medical University of Vienna10 enrolled1 locationNCT04989439
Recruiting

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

Congenital Myasthenic Syndrome
argenx100 enrolled32 locationsNCT06078553
Recruiting
Phase 2Phase 3

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis440 enrolled117 locationsNCT06943755
Recruiting
Phase 3

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals904 enrolled168 locationsNCT06091865
Recruiting
Phase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled225 locationsNCT06226883
Recruiting

INNODIA Family & Friends Early-Stage T1D Detection Protocol

Pre-diabetesType 1 Diabetes (T1D)
INNODIA iVZW30,000 enrolled15 locationsNCT07118098
Recruiting
Not Applicable

The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes Mellitus

Gestational Diabetes Mellitus (GDM)
Medical University of Vienna40 enrolled2 locationsNCT07685015
Recruiting

Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin

Critical IllnessAlcohol MisuseIntensive Care (ICU)
Medical University of Vienna800 enrolled1 locationNCT07632716
Recruiting

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

Post Operative Pain
AtriCure, Inc.5,000 enrolled11 locationsNCT05110989
Recruiting

Tracking Results of Ablations to Combat AF Registry Generation 2

Atrial Fibrillation
AtriCure, Inc.10,000 enrolled29 locationsNCT05111015
Recruiting

DESTINY Breast Respond HER2-(Ultra)Low Europe

Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer+1 more
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2,295 enrolled211 locationsNCT05945732
Recruiting
Phase 3

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Follicular Lymphoma ( FL)
Regeneron Pharmaceuticals822 enrolled190 locationsNCT06091254
Recruiting

Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation

Validation Study of Molecular Diagnostic SystemDevelopment of Reporting System for Molecular DiagnosisIncorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta500 enrolled26 locationsNCT01299168
Recruiting

OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science

Cardiogenic ShockMechanical Circulatory SupportCardiogenic Shock Post Myocardial Infarction
Medical University of Vienna100 enrolled1 locationNCT07619144